Client Services: 201.528.9187

FHACT® takes the guess work out of cervical cancer screening

WATCH THE VIDEO >

CGI Expands Global Reach with Acquisition of Bioserve India

LEARN MORE >

CGI delivers results for complex, B-Cell cancers

LEARN MORE >

CGI Expands Global Reach with Acquisition of Bioserve India

LEARN MORE >

Excellence in Oncology

Our comprehensive array of integrated laboratory services adds significant value to the process of diagnosing cancer.

We Have Answers

If you have been diagnosed with a non-Hodgkin lymphoma (NHL) or Kidney cancer, we have important information for you.

Complete Program

World-class and proprietary capabilities for the diagnosis and prognosis of CLL and DLBCL.

Latest News

  • 20 Jan 15

Cancer Genetics, Inc. Launches Digital Platform to Enable Collaboration With Community Hospitals and Laboratories

- RUTHERFORD, N.J., Jan. 20, 2015 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc., (Nasdaq:CGIX) ("CGI" or "the company"), an emerging leader in DNA-based (read more...)

CGI Reports

Client Access To Patient Reports

order_test
$7.59
CGIX -0.21
order_test